These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10845721)

  • 41. Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.
    Patel PM; Flemming CL; Russell SJ; McKay IA; MacLennan KA; Box GM; Eccles SA; Collins MK
    Br J Cancer; 1993 Aug; 68(2):295-302. PubMed ID: 8347485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor.
    Karp SE; Farber A; Salo JC; Hwu P; Jaffe G; Asher AL; Shiloni E; Restifo NP; Mulé JJ; Rosenberg SA
    J Immunol; 1993 Feb; 150(3):896-908. PubMed ID: 8423345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells.
    Fujii S; Liu Y; Neda H; Itoh Y; Koshita Y; Takahashi M; Watanabe N; Kohgo Y; Niitsu Y
    Jpn J Cancer Res; 1994 Mar; 85(3):315-24. PubMed ID: 8188531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor size and concomitant tumor immunity.
    Deckers PJ; Davis RC; Mannick JA
    Surg Forum; 1972; 23(0):112-4. PubMed ID: 4671043
    [No Abstract]   [Full Text] [Related]  

  • 45. Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicity.
    Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Fima E; Hacham M; Huleihel M; Benharroch D
    Immunol Lett; 1993 Dec; 39(1):45-52. PubMed ID: 8144190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anchoring cytokines to tumor cells for the preparation of anticancer vaccines without gene transfection in mice.
    Nizard P; Gross DA; Babon A; Chenal A; Beaumelle B; Kosmatopoulos K; Gillet D
    J Immunother; 2003; 26(1):63-71. PubMed ID: 12514430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antilymphoma immunity caused by challenge with chemically modified lymphoma membranes: parameters of immunization.
    Gillette RW; Nevin P; Wunderlich DA
    J Reticuloendothel Soc; 1981 Nov; 30(5):331-9. PubMed ID: 7320994
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of the cytokine rhTNF-alpha on the population of mast cells in the growth of MethA fibrosarcoma--a TEM study.
    Terlikowski SJ; Nowak HF; Famulski W; Sulkowska M
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():199-200. PubMed ID: 11820606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor immune surveillance by tumor necrosis factor producing cells.
    Lattime EC; Stutman O
    Immunol Res; 1991; 10(2):104-13. PubMed ID: 1919168
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cytokine therapy of neoplasms].
    Niitsu Y; Kogo Y
    Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1413-5. PubMed ID: 1453063
    [No Abstract]   [Full Text] [Related]  

  • 51. Ectopically Expressed Membrane-bound Form of IL-9 Exerts Immune-stimulatory Effect on CT26 Colon Carcinoma Cells.
    Do Thi VA; Park SM; Lee H; Kim YS
    Immune Netw; 2018 Feb; 18(1):e12. PubMed ID: 29503742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane-bound p35 Subunit of IL-12 on Tumor Cells is Functionally Equivalent to Membrane-bound Heterodimeric Single Chain IL-12 for Induction of Anti-tumor Immunity.
    Kim HJ; Park SM; Lee H; Kim YS
    Immune Netw; 2016 Oct; 16(5):305-310. PubMed ID: 27799876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor Cell Clone Expressing the Membrane-bound Form of IL-12p35 Subunit Stimulates Antitumor Immune Responses Dominated by CD8(+) T Cells.
    Lim H; Do SA; Park SM; Kim YS
    Immune Netw; 2013 Apr; 13(2):63-9. PubMed ID: 23700396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains.
    Pan WY; Lo CH; Chen CC; Wu PY; Roffler SR; Shyue SK; Tao MH
    Mol Ther; 2012 May; 20(5):927-37. PubMed ID: 22334018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor Therapy Applying Membrane-bound Form of Cytokines.
    Kim YS
    Immune Netw; 2009 Oct; 9(5):158-68. PubMed ID: 20157604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel method to incorporate bioactive cytokines as adjuvants on the surface of virus particles.
    Yang Y; Leggat D; Herbert A; Roberts PC; Sundick RS
    J Interferon Cytokine Res; 2009 Jan; 29(1):9-22. PubMed ID: 19014337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity.
    Kim YS; Sonn CH; Paik SG; Bothwell AL
    Gene Ther; 2000 May; 7(10):837-43. PubMed ID: 10845721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.